BioCentury
ARTICLE | Company News

Gliatech receives FDA integrity letter

December 26, 2000 8:00 AM UTC

GLIA said it received an Application Integrity Policy letter from the FDA regarding the recording and presentation of data from a post-marketing study of Adcon-L bioresorbable barrier gel to prevent s...